Uptake of biosimilars on the rise in the US, but number of marketed products lags other countries
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesEuropeNorth AmericaProduct LifecycleRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesEuropeNorth AmericaProduct Lifecycle